Cardiology Updates New York

New York City, NY | November 11, 2020

Jacob K. Javits Convention Center


The following financial relationships have been disclosed by faculty:  

Financial Disclosures

Peter Libby, MD
No financial disclosures

Other Disclosures

Peter Libby, MD has disclosed that he declines all personal compensation from all pharma or device companies. He has additionally disclosed the following competing interests: Grant/Research support: Novartis; Unpaid Consultant/Research:  Amgen, AstraZeneca, Esperion Therapeutics, Ionis Pharmaceuticals, Kowa Pharmaceuticals, Novartis, Pfizer, Sanofi-Regeneron, and XBiotech, Inc; Unpaid Scientific Advisory Board: Amgen, Covidia Therapeutics, DalCor Pharmaceuticals, IFM Therapeutics, Kowa Pharmaceuticals, Olatec Therapeutics, Medimmune, Novartis, XBiotech, Inc.

All non-faculty contributors to planning, development, editing and review of content have disclosed no relevant financial relationships.